TWIST1 Gene expression as a biomarker for predicting primary doxorubicin resistance in breast cancer
By: S Demir, MH Müslümanoğlu, M Müslümanoğlu, S Başaran, ZZ Çalay, A Aydıner, U Vogt, T Çakır, H Kadıoğlu and S Artan
Authors
S Demir
Eskişehir Osmangazi University Faculty of Medicine Department of Medical Genetics, Eskişehir, Turkey
Trakya University, Faculty of Medicine, Department of Medical Genetics, Edirne, Turkey
MH Müslümanoğlu
Yıldız Technical University Faculty of Science and Literature Department of Molecular Biology and Genetics, Istanbul, Turkey
M Müslümanoğlu
Bezmialem University Faculty of Medicine Department of General Surgery, Istanbul, Turkey
S Başaran
Istanbul University Faculty of Medicine Department of Medical Genetics, Istanbul, Turkey
ZZ Çalay
Istanbul University Cerrahpaşa Medical Faculty Department of Pathology, Istanbul, Turkey
A Aydıner
Istanbul University Faculty of Medicine Department of Medical Oncology, Istanbul, Turkey
U Vogt
European Laboratory Association ELA, Ibbenbueren, Germany
T Çakır
Gebze Technical University Faculty of Engineering Department of Bioengineering, Istanbul, Turkey
H Kadıoğlu
Medicana Hospital, Department of General Surgery, Bahçelievler, İstanbul, Turkey
S Artan
Eskişehir Osmangazi University Faculty of Medicine Department of Medical Genetics, Eskişehir, Turkey
DOI: https://doi.org/10.2478/bjmg-2019-0025 | Journal eISSN: 2199-5761
Language: English
Page range: 25 - 30
Published on: Dec 21, 2019
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2019 S Demir, MH Müslümanoğlu, M Müslümanoğlu, S Başaran, ZZ Çalay, A Aydıner, U Vogt, T Çakır, H Kadıoğlu, S Artan, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.